-
EP2508170
European procedure
Extract from the Register of European Patents
EP About this file: EP2508170
| EP2508170 - LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.06.2016 Database last updated on 18.11.2024 | Most recent event Tooltip | 06.10.2017 | Lapse of the patent in a contracting state New state(s): MT | published on 08.11.2017 [2017/45] | Applicant(s) | For all designated states Jiangsu Hengrui Medicine Co., Ltd. 145 Renmin Eastern Road Xinpu District Lianyungang, Jiangsu 222002 / CN | For all designated states Shanghai Hengrui Pharmaceutical Co. Ltd. 279 Wenjing Road Minhang District Shanghai 200245 / CN | [2012/41] | Inventor(s) | 01 /
TONG, Xinyong No.279 Wenjing Road Minhang District Shanghai 200245 / CN | 02 /
LEI, Guofeng No.279 Wenjing Road Minhang District Shanghai 200245 / CN | 03 /
YU, Chengxia No.279 Wenjing Road Minhang District Shanghai 200245 / CN | 04 /
CHEN, Liang No.279 Wenjing Road Minhang District Shanghai 200245 / CN | [2012/41] | Representative(s) | Pistolesi, Roberto, et al Dragotti & Associati Srl Via Nino Bixio, 7 20129 Milano / IT | [2012/41] | Application number, filing date | 09851784.0 | 03.12.2009 | WO2009CN75298 | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011066684 | Date: | 09.06.2011 | Language: | ZH | [2011/23] | Type: | A1 Application with search report | No.: | EP2508170 | Date: | 10.10.2012 | Language: | EN | [2012/41] | Type: | B1 Patent specification | No.: | EP2508170 | Date: | 29.07.2015 | Language: | EN | [2015/31] | Search report(s) | International search report - published on: | CN | 09.06.2011 | (Supplementary) European search report - dispatched on: | EP | 12.12.2013 | Classification | IPC: | A61K9/127, A61K31/4745, A61P35/00 | [2012/41] | CPC: |
A61K31/4745 (EP,KR,US);
A61K9/127 (EP,KR,US);
A61K47/02 (US);
A61K47/24 (US);
A61K9/0019 (EP,KR,US);
A61K9/1271 (EP);
A61K9/1277 (KR);
A61K9/1278 (EP,US);
A61K9/19 (EP,KR);
A61P35/00 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/41] | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | LIPOSOM AUS IRINOTECAN ODER SEINEM HYDROCHLORID UND HERSTELLUNGSVERFAHREN DAFÜR | [2012/41] | English: | LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND PREPARATION METHOD THEREOF | [2012/41] | French: | LIPOSOME D'IRINOTÉCAN OU SON HYDROCHLORURE ET SON PROCÉDÉ D'OBTENTION | [2012/41] | Entry into regional phase | 09.05.2012 | Translation filed | 09.05.2012 | National basic fee paid | 09.05.2012 | Search fee paid | 09.05.2012 | Designation fee(s) paid | 09.05.2012 | Examination fee paid | Examination procedure | 09.05.2012 | Examination requested [2012/41] | 06.06.2014 | Amendment by applicant (claims and/or description) | 26.02.2015 | Communication of intention to grant the patent | 15.06.2015 | Fee for grant paid | 15.06.2015 | Fee for publishing/printing paid | 15.06.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.02.2015 | Opposition(s) | 02.05.2016 | No opposition filed within time limit [2016/27] | Fees paid | Renewal fee | 09.05.2012 | Renewal fee patent year 03 | 20.12.2012 | Renewal fee patent year 04 | 23.12.2013 | Renewal fee patent year 05 | 11.12.2014 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MT | 29.07.2015 | IS | 29.11.2015 | [2017/45] |
| Former [2016/10] | IS | 29.11.2015 | Documents cited: | Search | [X]US2005118250 (TARDI PAUL [CA], et al) [X] 1-23 * examples 1,3-5 *; | [XI]EP1752150 (TERUMO CORP [JP], et al) [X] 1 * paragraphs [0093] - [0094] - [0097]; table 8 * [I] 2-23; | [XI]CN1960729 (TERUMO CORP [JP]) [X] 1 * paragraphs [0093] - [0094] - [0097]; table 8 * [I] 2-23; | [XI]CN1994279 (XIAN LIBANG MEDICINE SCIENCE A [CN]) [X] 1 * example 5 * [I] 2-23; | [X]US2009148506 (DICKO AWA [CA], et al) [X] 1-23 * pages 1-23 *; | [X] - CHOU T ET AL, "Effect of composition on the stability of liposomal irinotecan prepared by a pH gradient method", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, ELSEVIER, AMSTERDAM, NL, (20030101), vol. 95, no. 4, ISSN 1389-1723, pages 405 - 408, XP002503800 [X] 1-23 * the whole document * | [X] - QIU YONG-HONG ET AL, "Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes", JIANGSU DAXUE XUEBAO - JIANGSU UNIVERSITY. JOURNAL, JIANGSU DAXUE, JIANGSU, CN, (20090701), vol. 19, no. 4, ISSN 1671-7775, pages 314 - 319, XP008166064 [X] 1-23 * abstract; figures 1-5; tables 1-4; page 315, right column, lines 16-33; page 317, left column, lines 7-21 * | International search | [A]CN1323199 (ALZA CORP [US]); | [X]CN1650864 (UNIV FUDAN [CN]); | [X]CN1960729 (TERUMO CORP [JP]); | [X]CN1994279 (XIAN LIBANG MEDICINE SCIENCE A [CN]); | [X]CN101019834 (XI AN LIBANG MEDICINE SCI TECH [CN]); | [A]WO2008011427 (SYNTHA CORP [US], et al); | [X]CN101283983 (NANJING CHANGAO PHARMACEUTICAL [CN]); | [X] - QIU YONG-HONG ET AL., "Preparation and quality evaluation ofirinotecan hydrochloride lyophilized liposomes", JOURNAL OF JIANGSU UNIVERSITY(MEDICINE EDITION), (200907), vol. 19, no. 4, pages 314 - 317, XP008166064 | [X] - YANG JIAN-KUN ET AL., "Study on preparation of irinotecan hydrochloride liposomes and Influence factors", CHINESE JOURNAL OF NEW DRUGS, (2007), vol. 16, no. 23, pages 1962 - 1964, XP008166063 |